Douglas G Postels, MD | |
804 Service Rd, A217, East Lansing, MI 48824-7015 | |
(517) 353-8122 | |
(517) 432-3713 |
Full Name | Douglas G Postels |
---|---|
Gender | Male |
Speciality | Pediatrics - Neurodevelopmental Disabilities |
Location | 804 Service Rd, East Lansing, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740375914 | NPI | - | NPPES |
93673701 | Medicaid | NM | |
1740375914 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0008X | Pediatrics - Neurodevelopmental Disabilities | 2002-0239 (New Mexico) | Primary |
Entity Name | Childrens Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912939703 PECOS PAC ID: 0244143170 Enrollment ID: O20031107000130 |
News Archive
Despite an earlier payment cut, the proportion of U.S. physicians willing to treat Medicare patients stabilized in 2004-05, with nearly three-quarters reporting their practices were open to all new Medicare patients, according to a national study released by the Center for Studying Health System Change (HSC).
The ancient physician/alchemist, Paracelsus, said: "The dose makes the poison." According to a new study published in PeerJ, even oxygen may fall prey to the above adage. While essential to human life, aspects of oxygen metabolism may promote cancer. Capitalizing on the inverse relationship of oxygen concentration with elevation, researchers found lower rates of lung cancer at higher elevations, a trend that did not extend to non-respiratory cancers, suggesting that carcinogen exposure occurs via inhalation.
People who are blind from birth are able to detect tactile information faster than people with normal vision, according to a study in the Oct. 27 issue of The Journal of Neuroscience.
Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that its investigational new drug application (IND 109196) for its novel drug mibefradil has been accepted by the Food and Drug Administration (FDA).
Moody's Investors Service said its outlook for not-for-profit hospitals remains negative as weak revenue growth continues. The ratings agency called revenue projections for the coming 18 months "modest" in a newly released report and described sluggish revenue growth as the "single most significant challenge hospitals currently face."
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Douglas G Postels, MD 804 Service Rd, A201, East Lansing, MI 48824-7015 Ph: (517) 884-2976 | Douglas G Postels, MD 804 Service Rd, A217, East Lansing, MI 48824-7015 Ph: (517) 353-8122 |
News Archive
Despite an earlier payment cut, the proportion of U.S. physicians willing to treat Medicare patients stabilized in 2004-05, with nearly three-quarters reporting their practices were open to all new Medicare patients, according to a national study released by the Center for Studying Health System Change (HSC).
The ancient physician/alchemist, Paracelsus, said: "The dose makes the poison." According to a new study published in PeerJ, even oxygen may fall prey to the above adage. While essential to human life, aspects of oxygen metabolism may promote cancer. Capitalizing on the inverse relationship of oxygen concentration with elevation, researchers found lower rates of lung cancer at higher elevations, a trend that did not extend to non-respiratory cancers, suggesting that carcinogen exposure occurs via inhalation.
People who are blind from birth are able to detect tactile information faster than people with normal vision, according to a study in the Oct. 27 issue of The Journal of Neuroscience.
Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that its investigational new drug application (IND 109196) for its novel drug mibefradil has been accepted by the Food and Drug Administration (FDA).
Moody's Investors Service said its outlook for not-for-profit hospitals remains negative as weak revenue growth continues. The ratings agency called revenue projections for the coming 18 months "modest" in a newly released report and described sluggish revenue growth as the "single most significant challenge hospitals currently face."
› Verified 6 days ago
Dr. Melissa P Pieroni Long, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 307 W Lake Lansing Rd, East Lansing, MI 48823 Phone: 517-487-4480 Fax: 517-487-0193 | |
Dr. Bradley R. Hoopingarner, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 804 Service Rd # A110, East Lansing, MI 48824 Phone: 517-353-3003 Fax: 517-353-5514 | |
Dr. Marsha Dawn Rappley, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: A110 Clinical Ctr, 138 Service Rd, East Lansing, MI 48824 Phone: 517-353-3003 Fax: 517-353-5514 | |
Mr. David Lipsitz, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 307 W Lake Lansing Rd, East Lansing, MI 48823 Phone: 517-487-4480 Fax: 517-487-0193 | |
Ashweena Gonuguntla, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 804 Service Rd, Suite A110, East Lansing, MI 48824 Phone: 517-353-3003 Fax: 517-353-5514 | |
Suad Khalil, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 804 Service Rd Ste A217, East Lansing, MI 48824 Phone: 517-353-8122 Fax: 517-432-3713 | |
Dr. Ashir Kumar, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: A110 Clinical Center, East Lansing, MI 48824 Phone: 517-353-3003 Fax: 517-353-5514 |